Hemoglobin S Polymerization Inhibitors [MoA] - N0000194028

Name: Table of NDC products with hemoglobin s polymerization inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194028
Pharmacologic Name	Hemoglobin S Polymerization Inhibitors
Pharmacologic Uses	hemoglobin S polymerization inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Hemoglobin S Polymerization Inhibitors

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Hemoglobin S Polymerization Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
72786-101	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, Film Coated	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE
72786-102	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, Film Coated	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE
72786-111	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, For Suspension	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE